MarketPeel
Insider Trading Intelligence
FL

Flagship Venturelabs Vi Llc

GENB
10% OWNER · GENERATE BIOMEDICINES, INC. · CIK 0001725008
FILING MIX · LIFETIME44%/56%
BUYS
8
SELLS
10
TOTAL VALUE
$75.00M
COMPANIES
1
ACTIVE SINCE
Feb 2026
HOLDINGS NOW
0
AVG SELL PX
TRADE KIND
SHOWING 18 / 18
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Flagship Venturelabs Vi Llc, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+0.00%-1.18%+1.18%+1.18%
14d1+0.00%-1.73%-2.53%+0.80%+0.80%
30d1+100.00%+9.37%-4.54%+13.90%+13.90%
60d1+100.00%+8.05%+4.99%+3.06%+3.06%
90d1+100.00%+7.81%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
GENB · 0 shares · as of Mar 2, 2026
03,816,1817,632,36211,448,54315,264,724SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
FLOW · 8 buys / 10 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
GENB
GENERATE BIOMEDICINES, INC.
SALE
2,109,7040Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
1,562,500$16.00$25.00M4,340,252Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
1,562,500$16.00$25.00M15,264,724Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
18,483,7850Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
1,265,8220Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
1,562,500$16.00$25.00M1,562,500Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
13,702,22413,702,224Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
2,777,7522,777,752Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
2,109,7040Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
2,531,6440Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
2,953,5860Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
17,016,2150Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
12,723,94012,723,940Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASE
987,491987,491Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
1,265,8220Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
1,500,0000Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
SALE
843,8810Mar 2, 2026Mar 2, 2026View →
GENB
GENERATE BIOMEDICINES, INC.
PURCHASEGRANT
Stock grant
29,56129,561Feb 26, 2026Mar 2, 2026View →
Other insiders · GENB
Loading peer insiders…
About this filer
CIK 0001725008
ROLE
10% Owner
PRIMARY
GENB
COMPANIES
1
ACTIVE SINCE
Feb 2026
MARKETPEEL · /INSIDER/0001725008DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback